logo-loader
RNS
GenIP PLC

GenIP PLC - Strategic Resale Alliance with Cardinal IP

RNS Number : 0764C
GenIP PLC
28 April 2026
 



 


 

28 April 2026

 

GenIP Plc

("GenIP" or the "Company")

 

Strategic Resale Alliance with Cardinal Intellectual Property

GenIP Plc (AIM: GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, announces a strategic alliance with  Cardinal Intellectual Property, Inc. ("Cardinal IP"), the leading U.S. provider of patent searching, managed docketing, AI patent drafting, AI amendment drafting, IP consulting, and IP annuity and renewal payment services, giving GenIP accelerated access to the US corporate market and a high-credibility distribution channel for its AI-enabled tools.

Highlights

·    The Alliance brings together GenIP's proprietary AI-driven analytics platform with Cardinal IP's industry leading professional services.

·    Cardinal IP is the premier IP services firm in the United States with deep operational scale and long standing client relationships, selected by the US Patent and Trademark Office (USPTO) to perform Patent Cooperation Treaty search services, and serves Fortune 500 corporations, government agencies and leading law firms.

·    The Alliance establishes a reciprocal sale relationship where both parties sell each others' products and services to their clients. This will expand the range of services each company can offer, establishing high margin, recurring service channels for both companies.

·    The Board considers this Alliance a material step in broadening GenIP's commercial footprint, given Cardinal IP's established position across major US corporate and legal innovation ecosystems.

Market Opportunity

The global IP services market exceeds $25bn annually (World Intellectual Property Organization), driven by rising patent filings, litigation activity, and sustained innovation investment.¹ Within this, the AI-enabled IP services segment is projected to exceed $8bn by 2030, with patent drafting and analytics among the fastest-growing subsegments.²

This Alliance creates a significant opportunity for GenIP to access the corporate and enterprise market. Global corporate R&D expenditure reached a historic high in 2024³ generating continuous and recurring demand for IP protection, portfolio management, and commercialisation support through the search, valuation, and analytics services this Alliance is structured to deliver. Cardinal IP's established Fortune 500 and law firm relationships provide GenIP with a direct distribution route into this segment at a scale its existing channels do not reach. GenIP's international network across 25+ countries extends the Alliance's addressable market beyond the United States.

Strategic Rationale

Few IP service providers combine the traditional IP operations at scale (Cardinal IP) with AI-driven analytics and automation (GenIP). This creates a differentiated, defensible market position in a sector that is beginning to adopt AI at scale.

The reciprocal fee structure provides a clear commercial pathway for both companies to generate incremental revenue from existing client relationships.

For GenIP

Revenue and margin acceleration: Cardinal IP provides a pipeline for subscription and repeat use AI services

Access to a large client base: GenIP's AI tools gain accelerated distribution into Cardinal IP's long-standing accounts

Credibility: Cardinal IP's established reputation strengthens GenIP's standing with corporations, law firms and research institutes

Scalability: Supports GenIP's transition toward a recurring revenue model, consistent with its platform growth strategy

Taken together, these factors strengthen GenIP's ability to participate in higher-value segments of the global IP services market using its existing operating model.

For Cardinal IP

International distribution: Access to GenIP's client network across 25+ countries at no capital cost, extending Cardinal IP's reach beyond its core US market

Expanded offering: GenIP's commercialisation analytics complement Cardinal IP's IP protection services across the full innovation lifecycle

New revenue streams: Incremental revenue from AI-assisted analytics at low marginal cost, without additional headcount

Melissa Cruz, CEO of GenIP, commented:

"This Alliance with Cardinal IP gives GenIP a credible distribution route into the corporate enterprise segment, the largest and most recurring part of the global IP services market. The fee structure is commercially grounded, with fees reaching up to 30% on AI-enabled drafting services, and the performance incentive built into the agreement ensures both parties are motivated to convert introductions into revenue. We have designated commercial teams on both sides and a clear go-to-market approach, and we look forward to adding value to both organisations and positioning GenIP at the forefront of the global IP services industry."

Nathan Frederick, Chief Operating Officer, Cardinal Intellectual Property, commented:

"Cardinal IP is strengthening its global presence through this new strategic alliance with GenIP. This collaboration allows us to access new international markets and deliver our top-tier IP services to a broader customer base. By combining Cardinal's industry-leading expertise with GenIP's innovative reach, we are set to drive accelerated sales growth and provide a wider array of services to a global audience."

About Cardinal Intellectual Property

Cardinal IP is the leading intellectual property services firm in the United States, serving Fortune 500 corporations, major law firms, and government agencies. Cardinal IP has been selected by the USPTO to perform Patent Cooperation Treaty search services. Further information: https://cardinal-ip.com

¹ WIPO, World Intellectual Property Indicators, 2023 ² Fortune Business Insights, AI in Legal Market, 2024 ³ WIPO, Global Innovation Index 2025, September 2025 ⁴ Parola Analytics, 2024 USPTO Patent Roundup

 

 

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc

Melissa Cruz, CEO 


Via Redchurch Communications




Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish / Asia Szusciak / Andrew Price

 

 


Tel:  +44 (0) 20 7628 3396

 

AlbR Capital Limited (Broker) 

Colin Rowbury

Jon Belliss

            

Tel: +44 (0)20 7399 9427

cr@albrcapital.com 

Jb@albrcapital.com

 

Redchurch Communications (Financial PR)

John Casey

 

 


genip@weareredchurch.com

 

 

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

Notes to Editors

 

About GenIP

 

GenIP is a next-generation business      at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

 

Service Offerings

 

GenIP operates through two synergistic service lines:

 

 

Service

Description

Value Proposition

Invention Intelligence Product Suite

AI-powered market intelligence reports assessing the commercial potential of emerging technologies

Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy

Talent and Executive Search Services

Executive search platform using machine learning and NLP to match innovation-driven organisations with commercialisation-ready leadership

De-risks scaling by aligning technical vision with proven executive capability

 

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

 

Vision & Strategy

 

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

 

●    Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●    Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●    Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUBSORNSUSUAR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

8 min read